Weekly Wrap-Up: Thanksgiving Serves Up Gains for Retail

The major U.S. benchmarks rallied to record highs during the holiday-shortened week

Karee Venema
Nov 25, 2016 at 10:52 AM
facebook twitter linkedin


It was a short week on Wall Street -- with markets closed Thursday for the Thanksgiving holiday and stock trading ending early at 1 p.m. ET today -- but there was certainly plenty of action to hold traders' attention. In fact, for the first time in 17 years, the Dow, S&P 500 Index (SPX), Nasdaq Composite (COMP), and Russell 2000 Index (RUT) simultaneously closed at all-time peaks. And while the two-day streak was broken on Wednesday, blue-chip and small-cap stocks continued their record-setting run ahead of the holiday -- with the the RUT widening its daily win streak to a 20-year best. Plus, all four major benchmarks are trading higher today, and on track for notable weekly gains -- although the round-number 19,000 mark could prove meddlesome for the Dow in the near term.

Drilling down on specific sectors, chipmakers roared higher throughout the Thanksgiving week -- echoing the historically bullish trend for semiconductors -- with the Market Vectors Semiconductor ETF (SMH) notching a record high of $71.77 on Wednesday, and on track for a nearly 2% weekly advance. Part of the upside was due to a positive write-up in Barron's last weekend, which specifically called out NVIDIA Corporation (NASDAQ:NVDA) and Advanced Micro Devices, Inc. (NASDAQ:AMD) as chip stocks with upside potential.

Retailers had quite a week, too, which should be expected, given the sector's historically positive price action in the lead-up to Black Friday -- with early numbers suggesting strong sales for the shopping holiday. Nevertheless, looking at the charts of several retail stocks, a number of names just popped up on a list of the most overbought S&P 500 Index (SPX) stocks compiled by Schaeffer's Senior Quantitative Analyst Rocky White -- including Macy's Inc (NYSE:M), which waxed optimistic on Apple Inc.'s (NASDAQ:AAPL) Thanksgiving Day sales -- suggesting near-term caution should be in place.

Elsewhere, a big sell-off in biotechs on Wednesday weighed on the COMP, causing it to be the only major U.S. benchmark to settle the session in negative territory. Pressuring the sector was a devastating turn of events for Juno Therapeutics Inc (NASDAQ:JUNO) and disappointing drug data for Eli Lilly and Co (NYSE:LLY). A severe price-target cut for embattled drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) only poured salt on the proverbial wound.

Elsewhere, gold prices tumbled as the U.S. Dollar Index (DXY) extended its trek into 13-year-high territory -- although several signs have emerged that the currency's momentum against the Japanese yen could slow. Nevertheless, December-dated gold futures were last seen down 0.3% at $1,188.90 -- on track to log a third straight weekly loss.

Looking ahead, both gold and the U.S. dollar could continue to be in focus next week, with a number of key economic reports due ahead of the December Fed meeting, with this week's release of the November meeting minutes taking a rather hawkish tone. Meanwhile, although short-term S&P bulls are likely hoping for a positive post-Black Friday week, traders should be aware of several stumbling blocks stocks are staring down at the moment.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 

Partnercenter